Leukocytosis, JAK2V617F Mutation, and Hemostasis in Myeloproliferative Disorders

Publisher： Karger

E-ISSN： 1424-8840|36|3-4|148-159

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.36, Iss.3-4, 2009-01, pp. : 148-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Detection of Acquired Janus Kinase 2 V617F Mutation in Myeloproliferative Disorders by Fluorescence Melting Curve Analysis

By Reading N. Scott   Lim Megan S.   Elenitoba-Johnson Kojo S.J.  

Molecular Diagnosis & Therapy, Vol. 10, Iss. 5, 2006-01 ,pp. : 311-317

Adis International

Access to resources Recommend Favorite

Proteolytic Matrix Metallopeptidases and Inhibitors in BCR-ABL1-Negative Myeloproliferative Neoplasms: Correlation with JAK2V617F Mutation Status

By  

Acta Haematologica, Vol. 126, Iss. 1, 2011-04 ,pp. : 54-62

Karger

Access to resources Recommend Favorite

Is the JAK2 V617F Mutation a Hallmark for Different Forms of Thrombosis?

By  

Acta Haematologica, Vol. 124, Iss. 1, 2010-07 ,pp. : 49-56

Karger

Access to resources Recommend Favorite

Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd‐Chiari Syndrome without myeloproliferative neoplasm

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 3, 2018-02 ,pp. : 443-445

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of JAK2V617F in B and T Cell Neoplasms: Identification of JAK2V617F Mutation of Undetermined Significance (JMUS) in the Bone Marrow of Three Individuals

By  

Acta Haematologica, Vol. 118, Iss. 4, 2007-11 ,pp. : 209-214

Karger

Access to resources Recommend Favorite